12:00 AM
Nov 22, 1999
 |  BC Week In Review  |  Company News  |  Deals

SuperGen, Stehlin Foundation for Cancer Research deal

SUPG acquired exclusive worldwide rights to camptothecin compounds and other anticancer compounds discovered by the foundation. SUPG already holds exclusive worldwide rights from...

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >